Skip to main content
. 2024 Mar 15;14:1330492. doi: 10.3389/fonc.2024.1330492

Table 2.

Tumor data of all patients.

Primary tumor N (%)
NSCLC 83 (24.4.)
SCLC 6 (1.8)
Breast 56 (16.5)
Melanoma 48 (14.1)
Colon/Rectum 25 (7.2)
Carcinoma of unknown primary 23 (6.7)
Renal cell carcinoma 21 (6.2)
Stomach/Esophagus 11 (3.3)
Gynecologic 11 (3.3)
Prostate 10 (2.9)
Seminoma 5 (1.5)
Thyroid 3 (0.9)
Hepatocellular carcinoma 3 (0.9)
Other 35 (10.3)